Web Stats Provided By Google Analytics

Monday, August 26, 2013

The Deal: Amgen Soars on $10.4B Onyx Deal

"We believe that Amgen is ideally suited to realize the full potential of Onyx's portfolio and pipeline for the benefit of physicians and patients," said Amgen CEO Robert Bradway in a statement.

http://www.thestreet.com/story/12018459/1/the-deal-amgen-soars-on-104b-onyx-deal.html

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts